Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a 3.408% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a CCCSc1nc2sc3c(c2c(=O)n1CC)CC(C)(C)OC3
b O=C(COC(=O)Cc1ccc(Cl)cc1)Nc1ccc2[nH]c(=O)[nH]c2c1
Answer: a. CCCSc1nc2sc3c(c2c(=O)n1CC)CC(C)(C)OC3
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCSc1nc2sc3c(c2c(=O)n1CC)CC(C)(C)OC3
CCCSc1nc2sc3c(c2c(=O)n1CC)CC(C)(C)OC3
4-ethyl-12,12-dimethyl-5-propylsulfanyl-11-oxa-8-thia-4,6-diazatricyclo[7.4.0.02,7]trideca-1(9),2(7),5-trien-3-one